Elsevier Partners With Tissue Viability Society
Journal of Tissue Viability expands reach
London, 29 August 2007 – Elsevier, a world-leading publisher of scientific, technical and medical information products and services is pleased to announce the formation of a publishing partnership with the Tissue Viability Society, an organization representing more than 1000 wound care specialists in the UK.
Under the agreement, Elsevier will assume publication of Journal of Tissue Viability, official journal of the Tissue Viability Society from January 2008.
Journal of Tissue Viability is concerned with all aspects of the occurrence and treatment of wounds, ulcers and pressure sores including patient care, pain, nutrition, wound healing, research, prevention, mobility, social problems and management. The journal's audience includes various professions involved in tissue viability; primarily nurses but with many doctors, engineers, scientists, pharmacists, podiatrists and other professions also represented.
Dr Mike Clark, Editor, said "The Tissue Viability Society is excited by the agreement with Elsevier to publish the Journal of Tissue Viability. This will enable the Journal of Tissue Viability to reach a wider audience of wound healing professionals world-wide so strengthening the reputation of the Journal. The journal content will be printed at a faster pace and will also be accessible electronically together with other Elsevier journals. In addition, the submission and the reviewing of all manuscripts will be web-based, supported by Elsevier. This new procedure, which will be implemented shortly, will drastically reduce the reviewing process time and will be more cost-effective for the Journal."
Members of the Tissue Viability will continue to receive the print edition of Journal of Tissue Viability as a benefit of membership. In addition, members will be able to access the entire contents of each issue online. Other online features will include a comprehensive search engine, allowing users to search JTV alone, or to include hundreds of other Elsevier journals in a single query; options to sign up for e-mail alerts; and more. The Journal will be accessible through Elsevier's online database, ScienceDirect, the world's largest electronic collection of science, technology and medicine full text and bibliographic information.
# # #
About Tissue Viability Society
Formed in 1981 and a UK registered charity since 1996 the Society attracts members from all health care professions involved with tissue viability. The TVS mission statement: 'to disseminate information, promote research and increase awareness of all aspects of good clinical practice in wound prevention and management'.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
+44 207 424 4571